ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 292567 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 292567; 2) Community: the network communities that were significantly associated with the response to NSC 292567; 3) Molecule: the relationships between components within communities and NSC 292567; 4) MDR: the compounds that were significantly associated with the NSC 292567.

NSC Compound Enrichment Correlation
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0348927754043159 0.15073633
NSC 89671 Ascotoxin 0.0348927754043159 0.025343225
NSC 331935 CHALCONE ANALOG 0.0352786308082227 0.29707466
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0352786308082227 0.51057126
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.0352786308082227 0.47783322
NSC 633271 Null 0.0352786308082227 0.40528807
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0352786308082227 0.25780037
NSC 670688 Null 0.0352786308082227 0.28234447
NSC 688074 16,24-Cyclo-13,14-secoergost-2-ene-18,26-dioic acid, 5-chloro-14,17:14,27-diepoxy-6,13,20,22-tetrahydroxy-1,15-dioxo-, .gamma.-lactone .delta.-lactone 0.0352786308082227 0.30553087
NSC 10037 Null 0.0415729612483928 0.15041634
Total:37  Current:24    [First] [Prev] [Next] [Last]